These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19883008)

  • 41. [Application of endothelial progenitor cells in vascular tissue engineering].
    Zhao Y; Xu Z; Cai S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):476-8. PubMed ID: 18610646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease.
    Alobaid N; Alnaeb ME; Sales KM; Seifalian AM; Mikhailidis DP; Hamilton G
    Endothelium; 2005; 12(5-6):243-50. PubMed ID: 16410223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell therapies for therapeutic angiogenesis: back to the bench.
    Sieveking DP; Ng MK
    Vasc Med; 2009 May; 14(2):153-66. PubMed ID: 19366823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.
    Smadja DM; Bièche I; Silvestre JS; Germain S; Cornet A; Laurendeau I; Duong-Van-Huyen JP; Emmerich J; Vidaud M; Aiach M; Gaussem P
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2137-43. PubMed ID: 18818419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial progenitor cell mediates transport of hepatitis B.
    Rong QF; Huang J; Su EB; Li J; Li JY; Zhang LL; Chen LL; Wang XB; Cao KJ
    Chin Med J (Engl); 2008 Feb; 121(3):248-56. PubMed ID: 18298919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells.
    Traktuev DO; Prater DN; Merfeld-Clauss S; Sanjeevaiah AR; Saadatzadeh MR; Murphy M; Johnstone BH; Ingram DA; March KL
    Circ Res; 2009 Jun; 104(12):1410-20. PubMed ID: 19443841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial progenitor cells and exercise-induced redox regulation.
    Moebius-Winkler S; Schuler G; Adams V
    Antioxid Redox Signal; 2011 Aug; 15(4):997-1011. PubMed ID: 21091077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial progenitor cell-based neovascularization: implications for therapy.
    Krenning G; van Luyn MJ; Harmsen MC
    Trends Mol Med; 2009 Apr; 15(4):180-9. PubMed ID: 19303359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia.
    Sekiguchi H; Ii M; Losordo DW
    J Cell Physiol; 2009 May; 219(2):235-42. PubMed ID: 19115244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update.
    Napoli C; Hayashi T; Cacciatore F; Casamassimi A; Casini C; Al-Omran M; Ignarro LJ
    Atherosclerosis; 2011 Mar; 215(1):9-22. PubMed ID: 21126740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spartathlon, a 246 kilometer foot race: effects of acute inflammation induced by prolonged exercise on circulating progenitor reparative cells.
    Goussetis E; Spiropoulos A; Tsironi M; Skenderi K; Margeli A; Graphakos S; Baltopoulos P; Papassotiriou I
    Blood Cells Mol Dis; 2009; 42(3):294-9. PubMed ID: 19233694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ambivalence of progenitor cells in vascular repair and plaque stability.
    Hristov M; Weber C
    Curr Opin Lipidol; 2008 Oct; 19(5):491-7. PubMed ID: 18769230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial progenitor cells in cell-based therapy for cardiovascular disease.
    Rodriguez-Losada N; Garcia-Pinilla JM; Jimenez-Navarro MF; Gonzalez FJ
    Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54(1):11-23. PubMed ID: 18954547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proangiogenic cell-based therapy for treatment of ischemic diseases].
    Silvestre JS
    Med Sci (Paris); 2009 Nov; 25(11):931-8. PubMed ID: 19951667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial progenitor cells for cancer gene therapy.
    Debatin KM; Wei J; Beltinger C
    Gene Ther; 2008 May; 15(10):780-6. PubMed ID: 18369327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.
    Devanesan AJ; Laughlan KA; Girn HR; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):475-81. PubMed ID: 19560945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular disease: potential impact of stem cell therapy.
    Amrani DL; Port S
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):453-61. PubMed ID: 15030272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The imbalance between circulating endothelial cells and progenitors in cardiovascular diseases: a mirror of disrupted endothelial integrity.
    Bonello L; Sabatier F; Basire A; Paganelli F; Dignat-George F
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):607-13. PubMed ID: 16878722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial progenitor cells and cerebrovascular diseases.
    Lapergue B; Mohammad A; Shuaib A
    Prog Neurobiol; 2007 Dec; 83(6):349-62. PubMed ID: 17884277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models.
    Sata M
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1008-14. PubMed ID: 16456096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.